Skip to main content
. 2021 Jul 13;12(18):5454–5463. doi: 10.7150/jca.55727

Table 1.

Relationship between CLDN6 expression and clinicopathological parameters

Item n CLDN6 (+) CLDN6 (-) p
Differentiated degree
Highly differentiated 13 6 7 0.03*
Moderately differentiated 20 18 2
Poorly differentiated 15 14 1
Clinical stages
I-II 39 30 9 0.661
II-IV 9 8 1
Lymphatic metastasis
+ 3 2 1 0.203
- 45 36 9
Age (year)
≤55 22 18 4 0.735
>55 26 20 6
Gender
Man 36 27 9 0.414
Woman 12 11 1

*p<0.05